Your parent’s cardiologist prescribes a blood thinner. Their<\/p>\n
orthopedic doctor adds a pain medication. Their GP has been giving them a sleeping tablet for years. A neurologist recently added a memory drug. And somewhere along the way, they started taking a supplement for joint health that they ordered online.<\/p>\n
Nobody has looked at the full list together. Nobody has asked whether these medications interact. Nobody has checked whether some of them are still needed \u2014 or whether the side effects of one drug are being treated with another drug.<\/p>\n
This is<\/p>\n
poly-pharmacy. And in elderly patients in India, it is extremely common, poorly<\/p>\n
recognized, and frequently dangerous.<\/p>\n
poly-pharmacy<\/p>\n
The clinical definition of<\/p>\n
poly-pharmacy is the concurrent use of five or more medications by a single patient. In practice, many elderly patients in India \u2014 particularly those with diabetes, hypertension, heart disease, or arthritis \u2014 are on eight, ten, or even twelve medications simultaneously.<\/p>\n
The problem is not the number by itself. A patient with complex medical needs may genuinely require several medications. The problem is unreviewed, uncoordinated <\/strong><\/p>\n poly-pharmacy \u2014 where multiple specialists are prescribing independently, nobody holds the complete picture, and nobody has assessed whether the cumulative medication burden is helping or harming the patient.<\/p>\n Aging changes how the body processes medication. The kidneys and liver \u2014 which<\/p>\n metabolize and excrete drugs \u2014 become less efficient. Body composition shifts, changing how drugs are distributed in the body. The brain becomes more sensitive to certain drug classes. These physiological changes mean that a dose appropriate for a 45-year-old can be toxic in a 75-year-old.<\/p>\n At the same time, older patients are more likely to have multiple conditions requiring multiple drugs. The combination creates a particular danger: drug-drug interactions<\/strong> and drug-disease interactions<\/strong> that no individual prescriber is in a position to catch.<\/p>\n Here are some common but underrecognised examples:<\/p>\n One of the most common patterns in<\/p>\n<\/div>\n poly-pharmacy<\/p>\n is the prescribing cascade: a drug causes a side effect, which is misidentified as a new medical condition, which is then treated with another drug. For example: a calcium channel blocker causes ankle swelling \u2192 the swelling is treated with a diuretic \u2192 the diuretic causes potassium loss \u2192 potassium supplements are prescribed. The original cause \u2014 the calcium channel blocker \u2014 is never questioned.<\/p>\n<\/div>\n poly-pharmacy poly-pharmacy-related harm is that it is often mistaken for the symptoms of<\/p>\n aging itself. Families frequently say, “She’s just getting older \u2014 that’s why she’s so unsteady,” or “He’s always confused in the evenings now, it must be his age.” Sometimes, it’s the medications.<\/p>\n In India, specialist care is fragmented by design. Patients see a cardiologist for heart disease, a diabetologist for diabetes, a neurologist for any cognitive concerns, an<\/p>\n orthopedic surgeon for joint pain, and their neighbourhood GP for everything else. Each of these doctors is an expert in their own domain. None of them is responsible for the whole patient.<\/p>\n This is not a failure of individual doctors. It is a structural gap. Geriatric medicine exists precisely to fill this gap \u2014 to be the doctor who holds the whole picture, reviews the complete medication list, and makes decisions with the patient’s overall health and function as the priority, not just the numbers in a single domain.<\/p>\n poly-pharmacy<\/p>\n A structured medication review by a geriatric specialist examines every medication your parent takes \u2014 prescribed, over-the-counter, and supplements \u2014 against validated criteria (such as the Beers Criteria and STOPP\/START criteria) designed specifically for elderly patients. The goal is to identify medications that are inappropriate for older adults, interactions that increase risk, and medications that can be safely stopped \u2014 which is called deprescribing<\/em>.<\/p>\n<\/div>\n If your parent sees multiple specialists, there are some practical steps that can reduce risk even before a formal review:<\/p>\n The aim of a<\/p>\n poly-pharmacy review is not to take medications away. It is to ensure that every medication your parent is taking is doing more good than harm \u2014 and that the overall combination is as safe as it can be for someone of their age and medical complexity.<\/p>\n If you have concerns about your parent’s medication burden in Kolkata, a home visit from a geriatric specialist can include a full<\/p>\n poly-pharmacy review as part of a comprehensive geriatric assessment.<\/p>\nWhy it’s especially dangerous in older patients<\/h2>\n
\n
Signs that your parent may be harmed by<\/h2>\n
\nThe tricky thing about<\/p>\nThe Indian healthcare context makes this worse<\/h2>\n
What families can do<\/h2>\n
\n